Ybrain said it has signed a memorandum of understanding (MOU) with Meditrix, a digital medical device company, to collaborate on developing a digital treatment device for depression and various other digital healthcare products.The core content of the MOU is the future launch and marketing cooperati
Noul, an AI-based blood and cancer diagnostic platform company, said it presented the results of a clinical performance study of its malaria diagnostic solution at an African conference.The results show that the solution has a sensitivity of up to 94.4 percent and a specificity of up to 98.1 percent
Moderna and the Korean National Institute for Bioprocessing Research and Training (K-NIBRT) at Yonsei University have signed an agreement to develop mRNA education content and programs, accelerating the full-scale operation of the curriculum.The agreement follows a memorandum of understanding signed
Medical AI company Lunit said Thursday that it would present seven research studies using its AI biomarker platform, “Lunit SCOPE,” at the 2024 American Society of Clinical Oncology (ASCO 2024) in Chicago, U.S., from May 31 to June 4.Lunit will present a poster on identifying HER2 Ultra-Low breast c
Macrogen, a Korean digital healthcare company, said it held a groundbreaking ceremony for the Songdo Global Genome Center in Incheon. The company emphasizes that this facility is Asia's largest genomic big data hub in terms of data quantity. The construction, slated for completion by the second half
Onconic Therapeutics, a subsidiary of Jeil Pharma Holdings, said it received approval from the Ministry of Food and Drug Safety for Jaqbo (ingredient: Zastaprazan), a drug for the treatment of gastroesophageal reflux disease (GERD) and Korea's 37th domestically developed new drug.Jaqbo represents a
Severance Hospital researchers have identified a promising method to rejuvenate the effectiveness of natural killer cells in combating multiple myeloma, a serious form of blood cancer.Multiple myeloma is characterized by the malignant transformation of plasma cells, which are crucial to the body's i
Daewoong Pharmaceutical said Thursday that Fexuclue's prescription sales grew 57 percent year over year to 17 billion won ($12.4 million) in the first quarter of this year.According to drug statistics and information UBIST, seven products in the second-generation PPI series recorded negative growth
The Research Investment for Global Health Technology Foundation, commonly known as the RIGHT Foundation, said it opened its grant application aimed at significantly enhancing health equity in infectious disease sectors within low- and middle-income countries. The foundation is focusing its funding o
VUNO will exhibit its AI-powered cardiac arrest risk monitoring device, VUNO Med-DeepCARS, at the 44th Korean Society of Critical Care Medicine (KSCCM) Annual Congress-Acute and Critical Care Congress 2024, which will be held from Thursday to Friday.The company plans to showcase the superiority and
Professor Bang Jae-seung, chairman of the emergency committee of the Seoul National University College of Medicine and Seoul National University Hospital (SNUH) faculty council, will lay down both the chairmanship and professorship.Bang and three other medical professors who served on the emergency
Viatris Korea celebrated 25 years of Lipitor (atorvastatin) sales in Korea, highlighting its pivotal role in dyslipidemia treatment and cardiovascular diseases (CVD) prevention at a press conference in Seoul on Wednesday.After its launch in 1997, Lipitor became the top-prescribed statin in Korea by
Chong Kun Dang said it has entered into a licensing agreement with Curigin, a local gene therapy developer, for the latter's CA102, a gene therapy candidate targeting superficial bladder cancer.Founded in 2016, Curigin has pioneered the development of siRNA technologies capable of suppressing multip
"We are very sorry that we will be unable to be by your side."That's what the Department of Pediatric Nephrology professors at Seoul National University Hospital (SNUH) wrote in a notice to patients informing them of their resignations on Aug. 31. Only two professors are now working in the departmen
Attention is drawn to whether the reimbursement criteria for the multiple myeloma drug Darzalex (daratumumab), unchanged since May 2021, will be expanded for the first time in three years.Proposals to expand the reimbursement standard for the DVd (daratumumab/bortezomib/dexamethasone) and DKd (darat
Senior physicians at Seoul National University Hospital (SNUH) and Asan Medical Center (AMC) said they decided to refuse surgery and outpatient care by taking a day off every week in a growing protest against the government’s push to increase medical school enrollment quota. The emergency response c
Hanmi Pharmaceutical said it has entered into a clinical trial collaboration and supply agreement (CTCSA) with Merck & Co., Inc., known as MSD outside the U.S. and Canada.The partnership is set to advance the clinical research of Hanmi's dual-antibody therapy, BH3120, combined with MSD's immunothera
Pharos iBio said it has signed a memorandum of understanding with MEDiC Life Sciences, a Silicon Valley-based company that has established a gene-scissor technology (CRISPR) based cancer target and biomarker discovery platform, to collaborate on drug discovery.Through this agreement, the two compani
Samsung Bioepis said it has secured final product approval from the European Commission (EC) for its latest biosimilar, Pyzchiva, also known as SB17, a biosimilar candidate referencing Stelara.Stelara, originally developed by Janssen, is used for treating plaque psoriasis, psoriatic arthritis, Crohn
A top government official recently said that professors at even private medical schools, let alone national ones, are subject to the National Civil Service Act, raising the possibility that the ongoing conflict between the government and the political community could turn into legal disputes."Vice M